127 related articles for article (PubMed ID: 15519538)
1. Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.
Bertschy G; Ragama-Pardos E; Muscionico M; Aït-Ameur A; Roth L; Osiek C; Ferrero F
Pharmacol Res; 2005 Jan; 51(1):79-84. PubMed ID: 15519538
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
[TBL] [Abstract][Full Text] [Related]
4. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients.
Scharf MB; Sachais BA
J Clin Psychiatry; 1990 Sep; 51 Suppl():13-7. PubMed ID: 2211559
[TBL] [Abstract][Full Text] [Related]
5. A comparison of venlafaxine, trazodone, and placebo in major depression.
Cunningham LA; Borison RL; Carman JS; Chouinard G; Crowder JE; Diamond BI; Fischer DE; Hearst E
J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464
[TBL] [Abstract][Full Text] [Related]
6. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
7. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study.
Jacobsen FM
J Clin Psychiatry; 1990 Jul; 51(7):298-302. PubMed ID: 2365668
[TBL] [Abstract][Full Text] [Related]
8. Time course of clinical response to venlafaxine: relevance of plasma level and chirality.
Gex-Fabry M; Balant-Gorgia AE; Balant LP; Rudaz S; Veuthey JL; Bertschy G
Eur J Clin Pharmacol; 2004 Feb; 59(12):883-91. PubMed ID: 14704834
[TBL] [Abstract][Full Text] [Related]
9. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
[TBL] [Abstract][Full Text] [Related]
10. Trazodone for antidepressant-associated insomnia.
Nierenberg AA; Adler LA; Peselow E; Zornberg G; Rosenthal M
Am J Psychiatry; 1994 Jul; 151(7):1069-72. PubMed ID: 8010365
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
[TBL] [Abstract][Full Text] [Related]
12. Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study.
Savarese M; Carnicelli M; Cardinali V; Mogavero MP; Federico F
Arch Ital Biol; 2015; 153(2-3):231-8. PubMed ID: 26742677
[TBL] [Abstract][Full Text] [Related]
13. Trazodone: properties and utility in multiple disorders.
Mittur A
Expert Rev Clin Pharmacol; 2011 Mar; 4(2):181-96. PubMed ID: 22115401
[TBL] [Abstract][Full Text] [Related]
14. Possible trazodone potentiation of fluoxetine: a case series.
Nierenberg AA; Cole JO; Glass L
J Clin Psychiatry; 1992 Mar; 53(3):83-5. PubMed ID: 1548249
[TBL] [Abstract][Full Text] [Related]
15. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders.
Kallepalli BR; Bhatara VS; Fogas BS; Tervo RC; Misra LK
J Child Adolesc Psychopharmacol; 1997; 7(2):97-107. PubMed ID: 9334895
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
[TBL] [Abstract][Full Text] [Related]
17. Venlafaxine for treatment-resistant unipolar depression.
Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
[TBL] [Abstract][Full Text] [Related]
18. Patients with insomnia and subthreshold depression show marked worsening of insomnia after discontinuation of sleep promoting medication.
Wichniak A; Wierzbicka A; Jernajczyk W
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1671-6. PubMed ID: 21723905
[TBL] [Abstract][Full Text] [Related]
19. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
20. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
Nierenberg AA; Keck PE
J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
